Dianeal Pd4 Capd Solution with 1.5% Dextrose and 2.5meq/l Calcium 538 mg (Sodium Chloride SOLUTION) 538 MG

Dianeal PD4 CAPD Solution with 1.5% Dextrose and 2.5mEq/L Calcium is a peritoneal dialysis solution designed for intraperitoneal use. It contains sodium chloride and is used in the management of kidney failure.

Strength

538 MG

Manufacturer / TM Owner

VANTIVE ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dianeal PD4 CAPD Solution is primarily used for peritoneal dialysis, a process that cleans and filters the blood in individuals with kidney failure. This solution helps remove waste and excess fluids from the body when the kidneys are not functioning properly. It is administered through the peritoneal cavity, utilizing the body's natural membranes to filter blood.

Side Effects

Common effects of using Dianeal PD4 CAPD Solution may include discomfort or pain at the site of administration. Some individuals might experience bloating or fullness in the abdomen. It is important to monitor for any signs of infection or allergic reactions.

Precautions & Warnings

Handle Dianeal PD4 CAPD Solution with care, ensuring it is stored at the recommended temperature and kept away from direct sunlight. Always follow the instructions provided by your healthcare professional for proper administration. Regular monitoring and medical supervision are essential during its use.

Avoid Interactions

Dianeal PD4 CAPD Solution may interact with certain medications or supplements. It is important to inform your healthcare provider about all medications you are taking. Additionally, avoid using this solution if you are allergic to any of its components.

Frequently Asked Questions

Dianeal PD4 CAPD Solution is used for peritoneal dialysis in individuals with kidney failure. It helps remove waste and excess fluids from the body.

This solution is administered through the peritoneal cavity, typically by a healthcare professional. It is important to follow the specific instructions provided.

Common side effects may include discomfort or pain at the site of administration, bloating, and fullness in the abdomen.

It is important to inform your healthcare provider about all medications you are taking, as interactions may occur.

Store Dianeal PD4 CAPD Solution at the recommended temperature and keep it away from direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.